Article
Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge.
The Veterinary record - 23 Aug 2003
Hamers C, Couvreur B, Dehan P, Letellier C, Fischer L, Brun A J, Lewalle P, Michaux C, Pastoret P P, Kerkhofs P
Abstract excerpt
A new genotype of bovine viral diarrhoea virus (BVDV), designated BVDV-2, has emerged in the last decade and in recent years the prevalence of BVDV-2 strains has increased. A vaccination-challenge study was carried out to determine the cross-protective efficacy of a commercial inactivated vaccine containing a BVDV-1 strain. A group of five BVDV-free calves was vaccinated twice and a second group of five calves...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.